TNF enhances CD4+ T cell alloproliferation, IFN-γ responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms

Journal of Immunology

Volumn 170, Issue 10, 2003, Pages 5082-5088

  Brown, Geri R ^a,b   Lee, Edward L ^a,b   Thiele, Dwain L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT VERSUS HOST REACTION; INTESTINE; IRRADIATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; WEIGHT REDUCTION;

EID: 0037884818     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.10.5082     Document Type: Article

References (49)

1. Thomas, E. D., R. Storb, R. A. Clift, A. Fefer. F. L. Johnson, P. E. Neiman, K. D. Lemer, H. Glucksberg, C. D. Buckner, et al. 1975. Bone marrow transplantation II. N. Engl. J. Med. 292:895.
2. Thiele, D. L., M. L. Eigenbrodt, S. E. Bryde, H. H. Eigenbrodt, and P. E. Lipsky. 1989. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes. J. Clin. Invest. 83:1947.
3. Eigenbrodt, M. L., E. H. Eigenbrodt, and D. L. Thiele. 1990. Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease. Am. J. Pathol. 137:1065.
4. Korngold, R., and J. Sprent. 1985. Surface markers of T cells causing lethal graft-versus-host disease to class I vs class II H-2 differences. J. Immunol. 135:3004.
5. Krenger, W., G. Hill, and J. Ferrara. 1997. Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553.
6. Kirchian, K., F. P. Nestel, D. Kim, P. Ponka, and W. S. Lapp. 1996. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. J. Immunol. 157:2851.
7. Hill, G. R., T. Teshima, A. Gerbitz, L. Pan, K. R. Cooke, Y. S. Brinson, J. M. Crawford, and J. L. M. Ferrara. 1999. Differential roles of IL- and TNF-α on graft-versus-host disease and graft versus leukemia. J. Clin. Invest. 104:459.
8. Holler, E., H. J. Kolb, J. Mittermuller, M. Kaul, G. Ledderose, T. Duell, B. Seeber, M. Schleuning, R. Hintermeier-Knabe, B. Ertl, et al. 1995. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor α (TNFα) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNFα (MAK 195F). Blood 86:890.
9. Hill, G. R., T. Teshima, V. I. Rebel, O. I. Krijanovski, K. R. Cooke, Y. S. Brinson, and J. L. Ferrara. 2000. The p55 TNF-α receptor plays a critical role in T cell alloreactivity. J. Immunol. 164:656.
10. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant. Cell 73:457.
11. Brown, G. R., G. Lindberg, J. Meddings, M. Silva, B. Beutler, and D. L. Thiele. 1999. Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology 116:593.
12. Brown, G. R., and D. L. Thiele. 2000. T cell activation and differentiation are regulated by TNF during intestinal graft-versus-host disease. J. Clin. Immunol. 20:379.
13. 1 GVHD. J. Immunol. 168:3065.
14. Scott, P. 1991. IFN-γ modulates the early development of Th1 and Th2 response in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
15. Maggi, E., P. Parronchi, R. Manetti, C. Simonelli. M. P. Piccinni, F. S. Rugiu, M. DeCarli, M. Ricci, and S. Romagnani. 1992. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148:2142.
16. Parronchi, P., M. DeCarli, R. Manetti, C. Simonelli, S. Sampognaro, M. P. Piccinni, D. Macchia, E. Maggi, G. Del Prete, and S. Romagnani. 1992. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977.
17. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
18. + T cells for TCR transgenic mice: IL-12 can substitute for macrophages to stimulate IFN-γ production. Int. Immunol. 5:1119.
19. Manetti, R., P. Parronchi, M. G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri. and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type I (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
20. Powrie, F., and R. L. Coffman. 1993. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14:270.
21. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
22. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Thl cells. Immunol. Today 14:335.
23. Zhong, Z., Z. Wen, and J. E. Darnell. 1994. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. USA 91:4806.
24. Kaplan, M. H., A. L. Wurster, and M. J. Grusby. 1998. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type I cells. J. Exp. Med. 188:1191.
25. Satoskar, A. R., M. Okano, S. Connaughton, S. Raisanen, J. R. David, and M. Labow. 1998. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 28:2066.
26. Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, and M. Paskind. 1997. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386:619.
27. Gu, Y., K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M. A. Fleming, N. Hayashi, K. Higashino, H. Okamura, and K. Nakanishi. 1997. Activation of interferon-inducing factor mediated by interleukin-1 converting enzyme. Science 275:206.
28. Mytar, B., M. Woloszyn, I. Ruggiero, J. Pryjma., and M. Zembalam. 1995. Monocyte-mediated regulation of antigen-driven IFNγ production by T cells: the role of endogenously produced TNF. Immunol. Invest. 24:897.
29. Brown, G. R., M. J. McGuire, and D. L. Thiele. 1993. Dipeptidyl peptidase 1 is enriched in granules of in vitro and in vivo activated cytotoxic T lymphocytes. J. Immunol. 150:4733.
30. Brown, G. R., and D. L. Thiele. 2000. Enhancement of class I MHC stimulated alloresponses by 55kDa TNF receptor and class II MHC stimulated alloresponses by 75kDa TNF receptor. Eur. J. Immunol. 30:2900.
31. Leibnitz, R. R., P. E. Lipsky, and D. L. Thiele. 1994. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease. J. Immunol. 153:4959.
32. Kolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91:215.
33. Peppel, K., D. Crawford, and B. Beutler. 1993. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174:1483.
34. Sale, G. E., H. M. Shulman, G. B. McDonald, and E. D. Thomas. 1979. Gastrointestinal graft-versus-host disease in man: a clinicopathologic study of the rectal biopsy. Am. J. Surg. Pathol. 3:291.
35. Snover, D. C. 1990. Graft-versus-host disease of the gastrointestinal tract. Am. J. Surg. Pathol. 14:101.
36. Badovinac, V. P., and J. T. Harty. 2000. Intracellular staining for TNF and IFN-γ detects different frequencies of antigen specific CD8-T cells. J. Immunol. Methods 238:107.
37. Wu, C. Y., X. Wang, M. Gadina, J. J. O'Shea, D. H. Presky, and J. Magram. 2000. IL-12 receptor (β2 (IL-12Rβ2)-deficient mice are defective in IL-12 mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 165:6221.
38. Fantuzzi, G., A. J. Puren, M. W. Harding, D. J. Livingston, and C. A. Dinarello. 1998. Interleukin-18 regulation of interferon γ production and cell proliferation as shown in interleukin-1-converting enzyme (caspase-1)-deficient mice. Blood 91:2118.
39. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-production and activates IRAK and NF-B. Immunity 7:571.
40. Matsumoto, S., K. Tsuji-Takayama, K. Aizawa, K. Koide, M. Takeuchi, T. Ohta, and M. Kurimoto. 1997. Interleukin-18 activates NF-κB in murine T helper type I cells. Biochim. Biophys. Acta 234:454.
41. Kojima, H., M. Takeuchi, T. Ohta, Y. Nishida, N. Arai, M. Ikeda, H. Ikegami, and M. Kurimoto. 1998. Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochim. Biophys. Acta 244:183.
42. Micallef, M. J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, et al. 1996. Interferon-γ inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26:1647.
43. Cooke, K. R., A. Gerbitz, J. M. Crawford, T. Teshima, G. R. Hill, A. Tesolin, D. P. Rossignol, and J. L. M. Ferrara. 2001. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J. Clin. Invest. 107:1581.
44. Speiser, D. E., M. F. Bachmann, T. W. Frick, K. McKall-Faienza, E. Griffiths, K. Pfeffer, T. W. Mak, and P. S. Ohashi. 1997. TNF receptor p55 controls early acute graft-versus-host disease. J. Immunol. 158:5185.
45. Thiele, D. L., M. R. Charley, J. A. Calomeni, and P. E. Lipsky. 1987. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells. J. Immunol. 138:51.
46. Thiele, D. L., S. E. Bryde, and P. E. Lipsky. 1988. Lethal graft versus host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells. J. Immunol. 141:3377.
47. Schutze, S., K. Wiegmann, T. Machleidt, and M. Kronke. 1995. TNF-induced activation of NF-κB. Immunobiology 193:193.
48. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. U. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12 deficient mice are defective in IFN-γ production and type1 cytokine response. Immunity 4:471.
49. Welniak, L. A., B. R. Blazar, R. H. Wiltrout, M. R. Anver, and W. J. Murphy. 2001. Role of interleukin-12 in acute graft-versus-host. Transplant. Proc. 33:1752.